Skip to main content
Top
Published in: Rheumatology International 10/2012

01-10-2012 | Original Article

Concurrence of malignant fibrohistiocytoma and Takayasu arteritis: a case report

Authors: Jin-feng Du, Jin-wei Chen, Fen Li, Jing Tian, Xi Xie, Ni Mao

Published in: Rheumatology International | Issue 10/2012

Login to get access

Abstract

Takayasu arteritis (TA) is a type of systemic large-vessel vasculitis that usually affects the aorta and its major branches. It remains unrecognized owing to delayed diagnosis (Boltin et al. in Rheumatol Int 27(10):985–987, 2007) and non-characteristic clinical features. It has been described in association with many autoimmune diseases, such as inflammatory digestive tract diseases. However, report of TA associated with tumors, especially malignant tumors, are rare. We here presented a case diagnosed by both Takayasu arteritis and malignant fibrous histiocytoma, from which we learned not only clinical lessons, but also consensus of relationships between these two diseases.
Literature
1.
go back to reference Mok C, Kwok C, Ho L, Chan P, Yip S (2011) Life expectancy, standardized mortality ratios and causes of death of six rheumatic diseases in Hong Kong, China. Arthritis Rheum. doi:10.1002/art.30277 Mok C, Kwok C, Ho L, Chan P, Yip S (2011) Life expectancy, standardized mortality ratios and causes of death of six rheumatic diseases in Hong Kong, China. Arthritis Rheum. doi:10.​1002/​art.​30277
3.
go back to reference Jin-ling M, Jian C, Yu-tang W, Yan-yan G, Qing-yi M (2011) Etiology and clinical features of fever of unknown origin. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33(1):83–87PubMed Jin-ling M, Jian C, Yu-tang W, Yan-yan G, Qing-yi M (2011) Etiology and clinical features of fever of unknown origin. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33(1):83–87PubMed
4.
go back to reference Kager LM, van Eck-Smit B, Schreuder MC (2008) Fever of unknown origin. J Rheumatol 35(11):2276–2277PubMedCrossRef Kager LM, van Eck-Smit B, Schreuder MC (2008) Fever of unknown origin. J Rheumatol 35(11):2276–2277PubMedCrossRef
5.
go back to reference Abou-Jaoude M, El Ali M (2009) Malignant fibrous histiocytoma: a case report and literature review. Int Surg 94(3):196–200PubMed Abou-Jaoude M, El Ali M (2009) Malignant fibrous histiocytoma: a case report and literature review. Int Surg 94(3):196–200PubMed
6.
go back to reference Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21:309–313PubMedCrossRef Espinosa G, Font J, Munoz-Rodriguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21:309–313PubMedCrossRef
7.
go back to reference Lie JT (1995) Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 22:367–369PubMed Lie JT (1995) Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 22:367–369PubMed
8.
go back to reference Warrington KJ, Scheithauer BW, Michet CJ (2003) Acute myeloid leukemia associated with necrotizing temporal arteritis. J Rheumatol 30:846–848PubMed Warrington KJ, Scheithauer BW, Michet CJ (2003) Acute myeloid leukemia associated with necrotizing temporal arteritis. J Rheumatol 30:846–848PubMed
9.
go back to reference Solans-Laque R, Bosch-Gil JA, Perez-Bocanegra C, Selva-O’Callaghan A, Simeon-Aznar CP, Vilardell-Tarres M (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35:294–304PubMed Solans-Laque R, Bosch-Gil JA, Perez-Bocanegra C, Selva-O’Callaghan A, Simeon-Aznar CP, Vilardell-Tarres M (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35:294–304PubMed
10.
go back to reference Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Pena-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA et al (2007) Cancer in biopsy-proven giant cell arteritis. A population-based study. Semin Arthritis Rheum 37:156–163PubMedCrossRef Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, Pena-Sagredo JL, Lopez-Agreda H, Miranda-Filloy JA et al (2007) Cancer in biopsy-proven giant cell arteritis. A population-based study. Semin Arthritis Rheum 37:156–163PubMedCrossRef
11.
go back to reference B’Chir Hamzaoui S, Abdallah M, Baili L (2006) Takayasu’s arteritis associated with acute myeloblastic leukemia. J Mal Vasc 31(5):280–283PubMedCrossRef B’Chir Hamzaoui S, Abdallah M, Baili L (2006) Takayasu’s arteritis associated with acute myeloblastic leukemia. J Mal Vasc 31(5):280–283PubMedCrossRef
12.
go back to reference Canavero S, Pagni CA (1990) Meningioma and Takayasu disease: case report. Ital J Neurol Sci 11(4):393–394PubMedCrossRef Canavero S, Pagni CA (1990) Meningioma and Takayasu disease: case report. Ital J Neurol Sci 11(4):393–394PubMedCrossRef
13.
go back to reference Boltin D, Wollman J, Anouk M, Goor Y, Ablin J, Gur HG, Caspi D, Elkayam O (2007) Large aorta and narrow arteries: two short stories of too long diagnostic delay. Rheumatol Int 27(10):985–987PubMedCrossRef Boltin D, Wollman J, Anouk M, Goor Y, Ablin J, Gur HG, Caspi D, Elkayam O (2007) Large aorta and narrow arteries: two short stories of too long diagnostic delay. Rheumatol Int 27(10):985–987PubMedCrossRef
Metadata
Title
Concurrence of malignant fibrohistiocytoma and Takayasu arteritis: a case report
Authors
Jin-feng Du
Jin-wei Chen
Fen Li
Jing Tian
Xi Xie
Ni Mao
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2156-8

Other articles of this Issue 10/2012

Rheumatology International 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine